Kowalski Christine R Insider Trades

Insider Trading History

Track insider trading activity for Kowalski Christine R. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Intersect ENT
Intersect ENT XENT
EVP & Chief Operating Officer
Holding Value $1.16M 41,042 shares
Last Trade
Feb 04, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$29.6k 1,227 shares
$24.16
$28.24
Intersect ENT
Intersect ENT XENT
EVP & Chief Operating Officer
Holding Value $1.19M 42,269 shares
Last Trade
Feb 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.04M 44,984 shares
$23.07
$28.24
Intersect ENT
Intersect ENT XENT
Chief Operating Officer
Holding Value $763k 27,035 shares
Last Trade
Feb 03, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.01M 38,690 shares
$26.18
$28.24
Intersect ENT
Intersect ENT XENT
Chief Operations Officer
Holding Value $214k 7,595 shares
Last Trade
Jan 02, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$105k 4,357 shares
$24.15
$28.24
Intersect ENT
Intersect ENT XENT
Chief Operations Officer
Holding Value $338k 11,952 shares
Last Trade
May 07, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$300k 11,952 shares
$25.10
$28.24
Intersect ENT
Intersect ENT XENT
Chief Operations Officer
Holding Value $2.26M 80,000 shares
Last Trade
Nov 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.34M 80,000 shares
$29.28
$28.24

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up